Becton Dickinson & Co (NYSE:BDX)
$ 221.9 -0.08 (-0.04%) Market Cap: 64.16 Bil Enterprise Value: 82.13 Bil PE Ratio: 37.36 PB Ratio: 2.48 GF Score: 85/100

Becton Dickinson and Co at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2021 / 12:30PM GMT
Release Date Price: $256.49 (+2.32%)
Robert Justin Marcus
JPMorgan Chase & Co, Research Division - Analyst

Good morning, everyone. Happy to kick off the second day of the JPMorgan Healthcare Conference. I'm the medtech analyst here, Robbie Marcus, and I'm very happy to have CEO, Tom Polen, of Becton, Dickinson, leading our next presentation.

A few quick housekeeping items before we jump in. Feel free to go ahead and grab the slides from the JPMorgan Health Care website, you can follow along. There's also an ask a question button, feel free to submit a question for Q&A, that goes just directly to me, or e-mail me or chat me on Bloomberg, and I'll do my best to ask all the questions once we get to Q&A.

So with that, Tom, take it away.

Kristen Marie Stewart
Becton, Dickinson and Company - SVP of Strategy & IR

Actually, Robbie, this is Kristen. I'm going to just jump in real quick and read some lovely forward-looking statements.

For those of you also who don't know me, I recently joined as the SVP of Strategy and Investor Relations. We issued a press

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot